Related content

A Randomised Trial Comparing Two Doses of the New Selective Aromatase Inhibitor Anastrozole (Arimidex) With Megestrol Acetate in Postmenopausal Patients With Advanced Breast Cancer

By Berry J.   Sahlberg P.   ARIMIDEX Study Group   Jonat W.   Howell A.   Blomqvist C.   Eiermann W.   Winblad G.   Tyrrell C.   Mauriac L.   Roche H.   Lundgren S.   Hellmund R.   Azab M.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 404-412

Elsevier

Access to resources Recommend Favorite

High-dose toremifene as first-line treatment of metastatic breast cancer resistant to adjuvant aromatase inhibitor: A multicenter phase II study

By                    

Oncology Letters, Vol. 3, Iss. 1, 2012-01 ,pp. : 61-65

Spandidos Publications

Access to resources Recommend Favorite

Aromatase inhibitor therapy and hair loss among breast cancer survivors

By Gallicchio Lisa   Calhoun Carla   Helzlsouer Kathy  

Breast Cancer Research and Treatment, Vol. 142, Iss. 2, 2013-11 ,pp. : 435-443

Springer Publishing Company

Access to resources Recommend Favorite

Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo

By Zhu Yuanxi  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1349-1362

Springer Publishing Company

Access to resources Recommend Favorite

Circulating Tumor Cells in Patients Undergoing Surgery for Primary Breast Cancer: Preliminary Results of a Pilot Study

By Biggers Brian  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 969-971

Springer Publishing Company

Access to resources Recommend Favorite